Palvella Therapeutics Statistics
Total Valuation
PVLA has a market cap or net worth of $270.73 million. The enterprise value is $199.07 million.
Market Cap | 270.73M |
Enterprise Value | 199.07M |
Important Dates
The next estimated earnings date is Thursday, May 15, 2025, before market open.
Earnings Date | May 15, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
PVLA has 11.02 million shares outstanding. The number of shares has increased by 24.08% in one year.
Current Share Class | 11.02M |
Shares Outstanding | 11.02M |
Shares Change (YoY) | +24.08% |
Shares Change (QoQ) | +92.52% |
Owned by Insiders (%) | 17.98% |
Owned by Institutions (%) | 17.21% |
Float | 6.29M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 4.32 |
P/TBV Ratio | 4.32 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.33, with a Debt / Equity ratio of 0.19.
Current Ratio | 7.33 |
Quick Ratio | 7.14 |
Debt / Equity | 0.19 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -3.27 |
Financial Efficiency
Return on equity (ROE) is -59.37% and return on invested capital (ROIC) is -22.38%.
Return on Equity (ROE) | -59.37% |
Return on Assets (ROA) | -18.39% |
Return on Invested Capital (ROIC) | -22.38% |
Return on Capital Employed (ROCE) | -18.50% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.25M |
Employee Count | 14 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 24.08 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 50.33 |
Average Volume (20 Days) | 90,708 |
Short Selling Information
The latest short interest is 182,844, so 1.66% of the outstanding shares have been sold short.
Short Interest | 182,844 |
Short Previous Month | 102,620 |
Short % of Shares Out | 1.66% |
Short % of Float | 2.91% |
Short Ratio (days to cover) | 0.40 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -14.10M |
Pretax Income | n/a |
Net Income | -17.43M |
EBITDA | n/a |
EBIT | -14.10M |
Earnings Per Share (EPS) | -$7.83 |
Balance Sheet
The company has $83.60 million in cash and $11.94 million in debt, giving a net cash position of $71.66 million or $6.50 per share.
Cash & Cash Equivalents | 83.60M |
Total Debt | 11.94M |
Net Cash | 71.66M |
Net Cash Per Share | $6.50 |
Equity (Book Value) | 62.61M |
Book Value Per Share | 5.69 |
Working Capital | 76.20M |
Cash Flow
Operating Cash Flow | -10.84M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
PVLA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -24.08% |
Shareholder Yield | -24.08% |
Earnings Yield | -6.44% |
FCF Yield | n/a |
Analyst Forecast
The average price target for PVLA is $44.43, which is 82.39% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $44.43 |
Price Target Difference | 82.39% |
Analyst Consensus | Strong Buy |
Analyst Count | 7 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |